Venture
Affiliations
SUNY
Technologies
Therapeutic
Indication
Basic Research
Drug Discovery
Molecular Diagnostic
Oncology
Orphan Diseases
Personalized Medicine
Website
www.nomocan.comUtilizing a novel immunologic approach, NomoCan Pharmaceuticals is developing a targeted therapy for the treatment and prognosis of the most aggressive human cancer, pancreatic cancer.
NomoCan Pharmaceuticals Team: